First-in-human Trial of CRISPR Gene-editing ANGPTL3 Safely Lowered Cholesterol and Triglycerides
Key Points: CTX310 is a first-in-class in vivo CRISPR-Cas9 therapy designed to…
Tag: CRISPR-Cas9
Key Points: CTX310 is a first-in-class in vivo CRISPR-Cas9 therapy designed to…